Sygenus

N/A

Report date: 2024/06/24 15:53:25

Base Information

Drug NameSygenus

Drug Alias NameMSC derived secretome (Cambium Bio)MSC- derived bioactive secretome (Cambium Bio)Secretome (Cambium Bio)Allogenic cell secretions (Cambium Bio)

ClassificationBiologics > Protein drugs

Mechanisms of ActionImmunostimulants

TargetsUpdating

Therapy Area/IndicationsWounds and Injuries

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryAustralia

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesCambium Bio Ltd

China Registration ClassN/A

Develop Information

Active CompaniesCambium Bio Ltd

Inactive CompaniesN/A

Active IndicationsWounds and Injuries

Inactive IndicationsN/A

Other Information

ATC CodeN/A